Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-015969
Filing Date
2021-06-29
Accepted
2021-06-29 19:37:02
Documents
1
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2809
  Complete submission text file 0001437749-21-015969.txt   4297
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
McIntyre Gail Frances (Reporting) CIK: 0001492646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 211059757

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations